[HTML][HTML] Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management

EA Gorman, CM O'Kane, DF McAuley - The Lancet, 2022 - thelancet.com
Acute respiratory distress syndrome (ARDS) is characterised by acute hypoxaemic
respiratory failure with bilateral infiltrates on chest imaging, which is not fully explained by …

[HTML][HTML] Prone position in ARDS patients: why, when, how and for whom

C Guérin, RK Albert, J Beitler, L Gattinoni, S Jaber… - Intensive care …, 2020 - Springer
In ARDS patients, the change from supine to prone position generates a more even
distribution of the gas–tissue ratios along the dependent–nondependent axis and a more …

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

L Evans, A Rhodes, W Alhazzani, M Antonelli… - Critical care …, 2021 - journals.lww.com
Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to
infection (1). Sepsis and septic shock are major healthcare problems, impacting millions of …

COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?

E Fan, JR Beitler, L Brochard, CS Calfee… - The Lancet …, 2020 - thelancet.com
The COVID-19 pandemic has seen a surge of patients with acute respiratory distress
syndrome (ARDS) in intensive care units across the globe. As experience of managing …

[HTML][HTML] Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

W Alhazzani, MH Møller, YM Arabi, M Loeb… - Intensive care …, 2020 - Springer
Background The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting …

[HTML][HTML] Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study

M Schmidt, D Hajage, G Lebreton, A Monsel… - The Lancet …, 2020 - thelancet.com
Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …

Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review

E Ortiz-Prado, K Simbaña-Rivera… - … and infectious disease, 2020 - Elsevier
Coronaviruses are an extensive family of viruses that can cause disease in both animals
and humans. The current classification of coronaviruses recognizes 39 species in 27 …

[HTML][HTML] 2019 Novel coronavirus: where we are and what we know

ZJ Cheng, J Shan - Infection, 2020 - Springer
There is a current worldwide outbreak of a new type of coronavirus (2019-nCoV), which
originated from Wuhan in China and has now spread to 17 other countries. Governments …

[HTML][HTML] Analgesia and sedation in patients with ARDS

G Chanques, JM Constantin, JW Devlin, EW Ely… - Intensive care …, 2020 - Springer
Abstract Acute Respiratory Distress Syndrome (ARDS) is one of the most demanding
conditions in an Intensive Care Unit (ICU). Management of analgesia and sedation in ARDS …

Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial

PF Dequin, N Heming, F Meziani, G Plantefève… - Jama, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) is associated with severe lung damage.
Corticosteroids are a possible therapeutic option. Objective To determine the effect of …